FPT-SOFTWARE
2.11.2022 03:02:38 CET | Business Wire | Press release
Vietnam's leading IT services provider FPT Software, a member company of FPT Corporation, announced its new alliance with Julie Sandlau, one of the world's leading jewelry producers, supporting the company to build its first smart jewelry manufacturing factory in Vietnam. The partnership is expected to enhance FPT Software's presence in the Nordic region and incorporate digital technologies into Julie Sandlau's production line, revolutionizing it with Smart factories, Artificial Intelligence, Robotics, and so on.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221101005835/en/
FPT Software and Julie Sandlau signed the strategic partnership (Photo: Business Wire)
The signing ceremony took place on November 1st, in Hanoi, Vietnam, within the framework of Vietnam-Denmark Business Summit Forum 2022, organized by the Embassy of Denmark in Vietnam, Vietnamese Government Office and the Vietnamese Ministry of Foreign Affair in Denmark.
Through this alliance, FPT Software becomes Julie Sandlau’s strategic partner, provides the company with an exclusive roadmap to build their first Smart factory and transform the traditional jewelry manufacturing process with digital technologies like Robotic Process Automation, Artificial Intelligence, and more. The new manufacturing plant is set to be completed by the end of 2023 in Hoa Lac Hi-tech Park, Vietnam's first and largest hi-tech industrial zone.
The newly established partnership also transforms Julie Sandlau's operations and work processes, from human resources, operational management, to accounting and so on. FPT Software's automation and robotic processing solutions help ease the usual back-office procedures, reduce workload and workforce, thereby promoting and accompanying Julie Sandlau's towards sustainable development. The strategic step also allows Julie Sandlau's to expand its operations to a strategic market like Vietnam and target potential customers here.
FPT Corporation Chairman Dr Truong Gia Binh said. “In the past five decades, Vietnam and Denmark have established a strong relationship, with many deals among companies of both countries. With this partnership with Julie Sandlau, FPT believes that we can help reinforce the tight relationship between both nations.”
“As Vietnam’s leading IT solutions provider, FPT is confident to help Julie Sandlau with their digital transformation process and expansion goals in the Vietnamese and Southeast Asian markets”, Chairman Binh added.
“Vietnam always has a special place in our hearts since we started our business in 2006 here in Hanoi, so we are very excited to continue our Vietnam journey investing and developing further into digitalization, AI, blockchain technology and robotics.”, said Julie Sandlau’s CEO Soren Roed Pedersen.
“For years we have been first movers with our strong focus on ESG and we are now ready to start our digital transformation together with FPT and thus further proving the great collaboration between Vietnam and Denmark. We find the core values and vision of FPT and Julie Sandlau are a great match as we aim to transform a jewelry industry from traditional manufacturing methods to a modern digital hub. We have obviously great ambitions for our partnership with FPT as our long term strategy for Vietnam will develop into much more than just manufacturing.”, he further added.
"Julie Sandlau is our first-ever client in the jewelry manufacturing industry. This gives us more opportunities to explore and amplify FPT Software's technology potentials, especially in building a smart manufacturing factory for a client in a peculiar industry as such.”, FPT Software Europe CEO Hai Le said. "I believe this partnership will allow us to strengthen our workforce and experience, particularly in providing digital transformation solutions for future manufacturing clients.", he added.
On nurturing and developing human resources, FPT Software will transfer expertise and provide comprehensive training to Julie Sandlau's employees in Vietnam, with a deep dive into Artificial Intelligence applications. This practice will turn Julie Sandlau the world's first jewelry manufacturer to involve emerging technology in its production process, supporting its goal of becoming a digital transformation hero in premium accessories production by 2025.
The strategic partnership allows the two companies' employees to exchange knowledge and experiences, with Julie Sandlau offering fresh graduates from FPT University and FPT Corporation's staffs internship and employment opportunities. The program aims to improve educational quality and develop a guaranteed career path for future industrial engineers for FPT students and employees.
About FPT Software
FPT Software is a part of FPT Corporation, a globally leading technology and IT services & solutions provider headquartered in Vietnam with nearly US$1.6 billion in revenue and 41,000 employees in 27 countries. As a pioneer in digital transformation, it delivers world-class services in Smart factories, Digital platforms, RPA, AI, IoT, Enterprise Mobility, Digital Product Development, Cloud, AR/VR, Business Applications, Application Services, Managed Services, and so on. The company has served 1,000+ customers worldwide, nearly 100 of which are Fortune Global 500 companies in the industries of Aerospace & Aviation, Manufacturing & Automotive, Banking, Finance & Insurance, Logistics & Transportation, Healthcare & Life Sciences, Retail, Utilities & Energy, and more. For further information, please visit http://www.fpt-software.com.
About Julie Sandlau
Julie Sandlau Vietnam is the manufacturing arm of Danish luxury Jewelry brand Julie Sandlau and have since 2006 been producing high quality jewelry for some of the largest jewelry brands in the world with a strong focus on environment, sustainability and governance. The factory is committed to the United Nations Global Compact, The UN Women Empowerment Principles, The Science Based Target Initiative and is a certified member of the Responsible Jewellery Council, the highest international standard of responsible business practices in the jewelry business. With a workforce of nearly 400 people in which the goldsmiths are specialised and educated in Danish craftsmanship traditions and skills, Julie Sandlau Vietnam has been a first mover in CSR in Vietnam for years, winning multiple awards. All Julie Sandlau Vietnam's jewelry are made from recycled precious metals and sustainable certified gem stones giving their customers and stakeholders the ultimate trust and confidence in mutual business.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005835/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom